advertising opportunities - crt meeting...devoted to cardiogenic shock • updates on drug-coated...

Advertise in the official CRT publications and get your message

to more than 20,000 interventional cardiovascular professionals.

CONTACT: Debbie Schapiro

202.877.7998

[email protected]

A D V E R T I S I N G O P P O R T U N I T I E S

NEWVENUE

CORONARY

CRT VALVE & STRUCTURAL

CRT ENDOVASCULAR

TECHNOLOGY & INNOVATION

ATHEROSCLEROSIS & RESEARCH

NURSES & TECHNOLOGISTS

IMAGING, PHYSIOLOGY & THERAPY

CRTmeeting.org @CRT_Meeting facebook.com/CRTMeeting9

TIMESPREVIEW EDITION • JANUARY 2019

MARCH 2 – 5, 2019

OMNI SHOREHAM HOTEL

WASHINGTON, DC

Ron Waksman, MD

Washington Hospital Center

110 Irving St. NW

Suite 6B4

Washington, DC 20010-3017

CRT 2019: An educational event without

borders for the interventional cardiologistTony Blair to

keynote CRT 2019

STAY CONNECTED

WITH CRT

@CRT_MEETING

@CRTMEETING

@CRTMEETING

▶ Follow CRT 2019 on

▶ Search #CRT2019 for the

most up-to-date meeting

news!

TONY BLAIR, WHO SERVED AS

Prime Minister of the United

Kingdom from 1997–2007, will

give the keynote presentation at

CRT 2019 in Washington, DC, on

Monday, March 4.

“We are excited to continue

our legacy of outstanding keynote

speakers at CRT,” said CRT 2019

Course Chairman Ron Waksman,

MD. “This

year, we

wanted to

look more

globally,

since medicine is global. Tony Blair

has fascinating insights into health

system reform, including global

med-tech innovation.”

CRT 2019 continued on page 14 »

KEYNOTE continued on page 14 »

PRSRT STD

U.S. POSTAGE

PAID

SAN ANTONIO, TX

PERMIT NO. 744

INSI

DE 3BRS, DES, DCB COURSE WILL

PEER INTO THE FUTURE OF

INTERVENTIONAL TECHNOLOGY5

10ONE-YEAR LOW-RISK TAVR ONE

OF MANY HIGHLY ANTICIPATED

CRT LATE-BREAKING TRIALS

PROPER PATIENT SELECTION

IS KEY TO A SUCCESSFUL

MITRACLIP® PROCEDURE

KEYNOTE

Monday, March 4

Tony Blair

Venue to be announcedCRT 2019 promises another

year of cutting-edge data

in a boutique setting. This

robust conference will unite

more than 200 fellows and

experts and 550 faculty from

around the world at the Omni Shoreham

Hotel in Washington, DC, March 2–5.

Ron Waksman, MD, CRT 2019

Course Chairman, and expert faculty

have meticulously planned courses and

sessions that share the most relevant, novel

techniques and updated research for the

modern interventional cardiologist.

“CRT is so convenient because all of the program-

ming is in the same hotel,” Dr. Waksman said. “We

have expert faculty and cutting-edge presentations in an

intimate setting.”

Drug-coated balloons will be a focus at this year’s

meeting, particularly with growth and interest in the

devices, good below-the-knee results and

more players emerging in endovascular,

periphery and coronary. Sessions will

discuss moving from paclitaxel balloons

to sirilomus drugs, along with the newest

stents and balloons.

Critical limb ischemia (CLI), or what Dr.

Waksman refers to as a “disease beyond a

word search,” will be addressed

in a one-hour

session, with talks on access site points,

consistent approaches to wound care and

cardiovascular evaluation and treatment.

Cardiogenic shock is not a new topic at

CRT, but this year, CRT will devote a specific track, CRT

Cardiogenic Shock, to the condition to elevate its visibility

and increase awareness of the deadly condition.

Dr. Waksman also spearheaded a new initiative, “PCI

Beyond Borders,” which emphasizes that PCI is on the

verge of being able to treat alm

ost every condition. This

Ron Waksman, MD

• A day dedicated to innovation in the CRT Innovations Hub

• A new CRT Cardiogenic Shock Track devoted to cardiogenic shock

• Updates on drug-coated balloons and drug-eluting stents

• The latest in endovascular and critical limb ischemia

• New “PCI Beyond Borders” initiative in the Coronary Track

• FDA Town Halls focused on open dialogue, device approvals

• Live case operated entirely by women for the second year

DON’T MISS AT CRT 2019

CRT 2019 LIVE CASE SITES

MedStar Washington

Hospital Center

Washington, DC

Mount Sinai

Medical Center

New York, NY

Northwell Health

Great Neck, NY

St. Francis Hospital

Roslyn, NY

University of

Illinois at Chicago

Chicago, IL

University of Washington

Medical Center

Seattle, WA

Lankenau Heart

Institute | Main

Line Health

Wynnewood, PA

Maria Cecilia Hospital

Cotignola, Italy

CRTmeeting.org @CRT_Meeting facebook.com/CRTMeeting

9TIMESSUNDAY • MARCH 3MARCH 2 – 5, 2019 OMNI SHOREHAM HOTEL WASHINGTON, DCHealth-care disparities create various

differences in patient outcomes

STAY CONNECTED WITH CRT@CRT_MEETING

@CRTMEETING

@CRTMEETING


▶ Search #CRT2019 for the most up-to-date meeting news!

DISPARITIES continued on page 14 »

TRIALS SCHEDULE continued on page 14 »

TRIALS OVERVIEW continued on page 10 »

INSIDE

157

4

WHAT IS THE CURRENT STATE OF RENAL DENERVATION?

TRICUSPID VALVE PROMISING, BUT CHALLENGES STILL AHEAD

NURSES AND TECHNOLOGISTS TRACK FOCUSES ON THE CATH LAB OF THE FUTURE

H ow well patients fare after presenting with

cardiovascular disease is influenced by race, ethnicity and gender, according to Wayne Batchelor, MD, MHS, FACC, FSCAI,

and experts presenting in the Sunday

Disparities: Inequalities in Interventional Cardiology

evening symposium and panel. “To level the playing field in terms of access

to the most effective and novel technologies and

pharmaceutical interventions, we need to recognize

these inequities and address them,” Dr. Batchelor said.

Dr. Batchelor and Kim Williams, MD, MACC, will

explore various aspects of disparities in health care,

including race and ethnicity, gender, the paucity of

women in interventional cardiology and the potential

for biased clinical-trial databases. Soledad O’Brien, an

award-winning journalist, documentarian, news anchor,

producer and philanthropist, and the new host of the

Sunday morning syndicated political show Matter of

Fact, will keynote the session.Cardiovascular clinical-trial databases are inherently

biased toward enrolling Caucasian men, Dr. Batchelor

FIFTEEN LATE-BREAKING TRIALS have been selected for CRT 2019. The trials will be presented in four sessions covering these topics: acute coronary syndrome and acute myocardial infarction, structural valve (mitral and aortic), new stent and scaffold technology, physiology and endovascular intervention.

Soledad O’Brien

Visit our Premier Suite in AMBASSADOR 1

©2019 Abbott. All rights reserved.

7937 CRT Daily Ad Center Spread_R2F.indd 1

1/29/19 2:55 PM

Wayne Batchelor, MD, MHS, FACC, FSCAI • Kim Williams, MD, MACC

8 a.m.–3:50 p.m. CRT Cardiogenic Shock Track Diplomat Ballroom 12:40 p.m.

Keynote Address given by Jean Chatsky during the Women & Heart Symposium Regency Ballroom

2–2:45 p.m. Women in Interventional Cardiology Performing Complex PCI Live Case Regency Ballroom

4:30–5:30 p.m. Late-Breaking Trials Session I Regency Ballroom 8:15 p.m.

Keynote Address given by Soledad O’Brien during the Disparities: Inequalities in Interventional Cardiology Evening Symposium Diplomat Ballroom

SUNDAY HIGHLIGHTS

EVENING SYMPOSIUM

SUNDAY • LATE-BREAKING TRIALS: SESSION I • 4:30–5:30 p.m. • REGENCY BALLROOM

Disparities: Inequalities in Interventional CardiologySunday • 7–9:30 p.m. | Diplomat BallroomTopics include:• Clinical-trial databases• Women in interventional cardiology

• Gender disparities• Race affecting care• Diets affecting health and outcomesKeynote: Soledad O’Brien • 8:15 p.m.

Rivaroxaban 2.5mg BID Combined With Dual Antiplatelet Therapy for the Prevention of Death/MI/Stroke: A Patient-Level Data Meta-Analysis of the ATLAS-ACS-2 TIMI-51 and COMMANDER HF TrialsC. Michael Gibson, MDImpact of Intravascular Ultrasound to Detect

Vulnerable Plaques and Vulnerable Patients: Insights From the Lipid-Rich Plaque (LRP) Study Ron Waksman, MD, FSCAI

AngeLmed for Early Recognition and Treatment of

STEMI (ALERTS) Trial: A Randomized, Prospective

Clinical Investigation C. Michael Gibson, MD3-Years BIO-RESORT: Results of the 3-Arm Randomized Study in All Comers, Treated With Contemporary Biodegradable- or Durable-Polymer-Coated Drug-Eluting Stents Clemens von Birgelen, MD, PhD, FESC

Late-breaking trials look into the future of interventional cardiology


9TIMESMONDAY • MARCH 4

MARCH 2 – 5, 2019

OMNI SHOREHAM HOTEL

WASHINGTON, DC

Tony Blair will offer health-care

reform insights in tonight’s keynote

STAY CONNECTED

WITH CRT

@CRT_MEETING

@CRTMEETING

@CRTMEETING



most up-to-date meeting news!

WOMEN continued on page 14 »

BLAIR continued on page 14 »

INSI

DE

41012

FDA VALVE AND STRUCTURAL

TOWN HALL FOCUSES ON

ADVANCING DEVICES

WHAT ARE SOME OF THE

GENDER-RELATED DISPARITIES

IN INTERVENTIONAL CARDIOLOGY?

MEET THE EDITORS OF

GLOBAL JOURNALS

Tony Blair, who served as Prime Minister of the

United Kingdom from 1997–2007, will give

the keynote presentation on Monday evening.

“We are excited to continue our legacy of

outstanding keynote speakers at CRT,” said

CRT 2019 Course Chairman Ron Waksman, MD. “This

year, we wanted to look more globally, since medicine is

global. Tony Blair has fascinating insights into

health-system reform, including global

med-tech innovation.”

Dr. Waksman will moderate this

fireside chat. During Mr. Blair’s time

in No. 10 Downing St., he became the

only leader in the Labour Party’s 100-

year history to win three consecutive

elections. In doing so, he redefined

modern, progressive politics.

While Prime Minister, Mr. Blair implemented

a major domestic reform agenda. Through record

investment and reform, the education and health-care

sectors were transformed.

Mr. Blair’s New Labour government implemented the

largest hospital and school building program since the

creation of the U.K.’s welfare state. Overall crime was

reduced by a third, and the first-ever national minimum

wage was introduced.

There was also transformational progress on

human rights and equality. He accomplished all of

this while overseeing a period of record economic

growth and levels of employment. Mr. Blair also

was a central figure on the global stage. He helped

bring peace to Northern Ireland, securing the

historic Good Friday Agreement in 1998.

As a passionate advocate of

an interventionist foreign

policy, he took military

action in Sierra Leone,

Kosovo, Afghanistan

and Iraq. Mr. Blair

created the Department

for International

Development, tripled

IF YOU WANT A LITTLE SELF-IMPROVEMENT, MONDAY’S

Women in Interventional Cardiology: Leaders in

Innovation program will focus on effective leadership

and communication. The program begins at 2 p.m. in

the Blue Pre-Function Ballroom.

“This interactive course is designed especially for

female cardiologists. We will receive practical advice about

presenting with confidence, honing a polished professional

brand, handling interruptions and speaking with conviction,”

said Alexandra Lansky, FACC, FAHA, FSCAI, FESC,

professor of medicine, section of cardiovascular medicine,

9:20 a.m.–4:45 p.m.

BRS, DES and DCB Technologies

Empire Ballroom

11:30 a.m.–12:30 p.m.

Late-Breaking Trials: Session II

Regency Ballroom

4:15–5:15 p.m.

Late-Breaking Trials: Session III

Regency Ballroom

8 p.m.

Keynote Address given by Tony Blair, Prime

Minister of the United Kingdom from 1997–2007

Regency Ballroom

MONDAY HIGHLIGHTS

Engaging session offers female cardiologists focused leadership training

Tony Blair

Alexandra Lansky, FACC,

FAHA, FSCAI, FESC

CRT KEYNOTE ADDRESS

Monday • 8 p.m.

Tony Blair, Prime Minister

of the United Kingdom from

1997–2007

Regency Ballroom

Tony Blair

Women in Interventional

Cardiology: Leaders in Innovation

Monday • 2–4 p.m.

Blue Pre-Function Ballroom

Topics include:• Effective leadership and

communication for women

• Honing a polished

professional brand

• Handling interruptions and

speaking with conviction

• Practicing pitches

COURSE




1/29/19 2:55 PM


9TIMESTUESDAY • MARCH 5

MARCH 2 – 5, 2019

OMNI SHOREHAM HOTEL

WASHINGTON, DC

‘Hey, Alexa,’ is changing the health-care world

STAY CONNECTED WITH CRT

@CRT_MEETING@CRTMEETING

@CRTMEETING



most up-to-date meeting news!

DCB TOWN HALL continued on page 11 »

AI continued on page 11 »

INS

IDE

3

810

MED-TECH ENTREPRENEURS

FACE OFF TO EARN CRT’S

‘TOP CARDIOVASCULAR INNOVATION AWARD’STROKE INTERVENTION IS

READY FOR PRIME TIMEVA ROUNDTABLE ADDRESSES

HIGH-RISK PCI PATIENTS,

STRUCTURAL PROGRAMS

I magine a world where Amazon’s

Alexa or Google’s Assistant took

care of all the pre-work for a clinic

visit so the clinicians could focus

on the important issues or remind

patients to pick up prescriptions and

take their medicines. That world might not be too

far away since last year the

e-commerce giant partnered with

JPMorgan and Berkshire Hathaway

to “revolutionize health care,” and

Alphabet (Google’s parent company)

formed Verily to deal with regulated

biomedical products. As society

is entering the fourth industrial

revolution, science and biomedicine

are becoming digitized, and

artificial intelligence (AI) is playing

a bigger role in health care. AI has

great promise to automate decision

support and improve patient

outcomes, but it comes with its

own set of challenges.

“Everybody—rank and file,

cardiologists, academic medical

centers, universities, companies

and the government—needs to be

talking right now about how we

set the standards, boundaries and

expectations of artificial intelligence,”

said Robert M. Califf, MD, MACC,

vice chancellor for health data

science at Duke University.

Dr. Califf, a former Food and

Drug Administration commissioner,

will address the benefits and

challenges of “Artificial Intelligence

in Clinical Cardiology” as the

keynote speaker during the HHS/

FDA Town Hall on Tuesday.

The benefits of AI are many, he

said. For one, an algorithm could

be created to scan electronic health

records and detect a pool of patients

that would benefit from transcatheter

aortic valve replacement, including

people in nursing homes and

extended-care facilities. Right now,

the procedure depends on a doctor

thinking of the possibility and

referring a patient, he said.

INTERVENTIONAL CARDIOLOGISTS HAVE WORKED WITH

paclitaxel-coated balloons for the past two decades

in the coronary and peripheral arenas. Tuesday’s DCB

(Drug-Coated Balloon) Safety Town Hall will analyze the

drug’s pharmacodynamics

following a meta-analysis

of clinical trial data that

suggests there might be

a deleterious effect from

paclitaxel with respect to

late mortality.

“If true, it’s an important issue for clinicians, patients

and for regulatory individuals,” said Jeffrey J. Popma,

MD, a session moderator. “The purpose of the town hall

meeting is really threefold: First, it’s to put together a

group of extremely renowned cardiologists, statisticians

and vascular surgeons, who would then listen to expert

speakers, who are then going to give us a broad overview

about both the paclitaxel effect to the coronary and

peripheral vessels, including the efficacy and toxicity.”

World-renowned experts will provide the panel with

guidance about how to interpret the data regarding the

long-term safety of paclitaxel. Konstantinos Katsanos,

MD, will present his “JAHA Meta-Analysis: What Is

the Case for Higher DCB and DES Mortality With

Paclitaxel”—“a very provocative but thought-provoking

analysis,” Dr. Popma said—while Gheorghe Doros, PhD,

7 a.m.–1 p.m. Hampton Ballroom

CRT Innovations Hub & Top

Cardiovascular Innovation Award

8–8:50 a.m. Regency Ballroom

Live case from Maria Cecilia

Hospital in Cotignola, Italy 8 a.m.–3:55 p.m. Empire Ballroom

DCB Safety Town Hall Meeting 8 a.m.–3 p.m. Palladian Ballroom

HHS/FDA Town Hall 1 p.m. Palladian Ballroom

Keynote Address given by Robert M. Califf,

MD, MACC, during HHS/FDA Town Hall

TUESDAY HIGHLIGHTS

DCB town hall focuses on the safety of paclitaxel

Robert M. Califf, MD, MACCKEYNOTE

Artificial Intelligence in Clinical Cardiology

Tuesday • 1 p.m. HHS/FDA Town HallRobert M. Califf, MD, MACC




1/29/19 2:55 PM

Jeffrey J. Popma, MD

TOWN HALLDCB Safety Town Hall8 a.m.–3:55 p.m.Empire Ballroom

CRT 2019 goes beyond borders

INSIDE

345

MITRAL CERCLAGE

ANGIOPLASTY WINS BEST

INNOVATION AWARD

LATE-BREAKING TRIALS

PRESENTED AT CRT 2019

CRT 2020 HEADS TO NEW LOCATION,

WELCOMES LARGER SPACE FOR MORE

HANDS-ON TRAINING

CRT 2019 lived up to its

theme “an educational

event with no borders,”

said Course Chairman Ron

Waksman, MD, FSCAI. Interventional

cardiologists, industry leaders, fellows

and regulators from all over the world

gathered in Washington, DC, from

March 2–5 to learn, educate and

share up-to-date information about

new cardiovascular technologies

and interventional procedures.

That exchange of information will

go beyond the meeting to impact

practice and care of patients.

CRT 2019 included 1,290

presentations and 20 live cases from

nine locations around the world.

Almost 3,000 people attended

the meeting, which continues to

grow and expand. The meeting

included 80 abstract and 80 case

presentations—more than ever

before—which allowed for more

interaction with the participants.

“It was a very successful meeting

this year,” Dr. Waksman said. “You

could hear the excitement and

vibration in the hallways. What’s

nice about CRT is we have a lot

of programs for fellows and young

leaders. We also invited key opinion

leaders and world-renowned speakers

from all over the world so the young

and the experienced could interact.”

The meeting featured different

forms of education, including

simulators, one-on-one meetings with

experts, live cases and workshops.

Fifteen late-breaking trials were

presented, with the highlight being

the Low-Risk Transcatheter Aortic

Valve Replacement (TAVR) Study.

The study revealed that one year

after procedure, TAVR is as safe and

effective as surgery.

Tony Blair, who served as Prime

Minister of the United Kingdom from

1997–2007, delivered the keynote

presentation on Monday, March 4.

In addition to addressing health-care

reform, Blair shared why he does not

support “Brexit,” (withdrawal of the

United Kingdom from the European

Union) and, in true British form,

chose fish and chips over hamburgers

in a rapid-fire question round.

BLAIR continued on page 10 »

DCB TOWN HALL continued on page 10 »

CRT 2019 continued on page 10 »

IT’S NO SECRET THAT TONY BLAIR,

former Prime Minister of the

United Kingdom, thinks “Brexit”

isn’t a good idea. His opening

words on the topic during his

fireside chat with Ron Waksman,

MD, FSCAI, were, “I don’t like it.”

The crowd rumbled with

laughter throughout Blair’s talk

as he commented on politics

with wit sprinkled throughout his

serious points.

PANELISTS AT THE DRUG-COATED BALLOON (DCB)

Safety Town Hall on the last day of CRT 2019 said

there is a safety signal for paclitaxel-coated devices

used in the femoral and popliteal arteries. They also

said that physicians recommending the use of these

devices should have a discussion with patients about

this safety signal.

The town hall’s focus was on the scrutiny that

paclitaxel-coated devices have received since a

meta-analysis by Konstantinos Katsanos, MD, PhD,

MSc, EBIR, of Patras University Hospital in Greece, and

colleagues, published in December in the Journal of the

American Heart Association. Dr. Katsanos and colleagues’

manuscript reported higher all-cause mortality in patients

undergoing treatment of femoropopliteal disease with

paclitaxel-coated devices than in control groups in 28

randomized controlled trials.

Paclitaxel device safety thoroughly discussed at CRT

Tony Blair talks

‘Brexit,’ royal ruling

and global politics

in keynote address

Ron Waksman, MD

Washington Hospital Center

110 Irving St. NW

Suite 6B4

Washington, DC 20010-3017

PRSRT STD

U.S. POSTAGEPAID

SAN ANTONIO, TX

PERMIT NO. 744


9TIMESPOST EDITION • APRIL 2019

MARCH 2 – 5, 2019

OMNI SHOREHAM HOTEL

WASHINGTON, DC

Abbott half-page banner

Former United Kingdom Prime Minister Tony Blair

(left) and CRT Course Chairman Ron Waksman,

MD, FSCAI

2,800

1,290

20

15

TOTAL ATTENDEES

PRESENTATIONS

LIVE CASES

LATE-BREAKING

TRIALS

JAPAN 29

EGYPT 13

ISRAEL 13SWITZERLAND 20

ITALY 22

GERMANY 18NETHERLANDS 16

SPAIN 8MEXICO 6

FRANCE 6

UNITED KINGDOM 31

CANADA 20

256 INTERNATIONAL ATTENDEES

Missed CRT 2019?

Subscribe to CRT Premium

for an exclusive look

at the meeting.

crtonline.org/premium

OTHER 41

SINGAPORE 4

AUSTRAILIA 1

BRAZIL 5

INDIA 3

CRT GUIDE CRT JACC SUPPLEMENTCRT DAILY

CRT DAILY TIMES - 3 EDITIONS

Audience and distributionDistributed to more than 2,500attendees via handout personnel and newspaper racks at key locations on each day of the meeting and 80,000 via digital distribution.

ContentInterviews from CRT, timely articles on research and trends interventional cardiology. Advertisers will have the option of a display ad or “Advertorial article in the publication.

Publication DatesFebruary 23, 24 & 25, 2020

DeadlinesSpace reservation: December 3, 2019Materials due: January 10, 2020

CRT Daily Times - 3 Editions

ContentThese three issue Daily providesattendees with interviews with course chairman Ron Waksman, MD, faculty members, exhibitor related events and breaking conference news.

CRT SUPPORTER, EXHIBITOR& SYMPOSIA GUIDE

• Create a lasting impression• Invite attendees to your booth • Feature your latest drug or device

ContentThe Guide contains company symposia details and information for CRT Supporters and Exhibitors.

DeadlinesSpace reservation/Payment due:January 10, 2020Materials due: January 24, 2020

Ad Size5-1/2" x 8-1/2"

CostFull page Ad - $500

JACC: CARDIOVASCULAR INTERVENTIONS: CRT SUPPLEMENT

Audience and distributionDistributed to more than 2,500 CRT attendees and mailed to over 20,500 interventional cardiology professionals.

ContentCRT Abstract submissions and CRT iMPACT Trials, CRT 2020 Course Directors, Faculty and Abstract Reviewers.

DeadlinesSpace reservation/Payment due:January 3, 2020Materials due: January 10, 2020

Ad Size8-1/4" x 11"

CostFull page Ad - $3,500

**Advertiser to provide cover flap

CRT ADVERTISING RATESSize Dimensions Fall Edition Daily - 3 editions CRT Guide CRT JACC

Full Page 9-1/2" X 13-1/4" $5,000 $15,000 $500 $3,500

Full Page PI 9-1/2" X 13-1/4" $2,000 $9,000

Junior Page 6" X 8-1/2" $8,500

Half Page 8-1/2" X 6" $8,500

Quarter Page 4" X 6" $7,500

Premium Positions

Back Cover 9-1/2" X 13-1/4" $17,500

Inside Front Cover 9-1/2" X 13-1/4" $16,000

Inside Back Cover 9-1/2” X 13-1/4” $16,000

Center Spread 19" X 13-1/4" $20,000

Page 1 Banner 9-1/2" X 1-1/2" $12,000

Cover Flap** 9-1/2" X 13-1/4" $15,000**

MedStar Washington Hospital Center • 110 Irving Street, NW • Suite 6B-4 • Washington, DC 20010

I have read and agree to the terms as set forth on this document.

Authorized Advertiser/Agency Signature & Title

__________________________Signature

_________________________Title/Date

CRT Daily, CRT Guide & CRT JACCSpace reservation/payment due: December 3, 2019Material due: January 10, 2020

Sales Contact Debbie [email protected]

Please remit payments to:MedStar Washington Hospital Center110 Irving Street, NWSuite 6B-4 Washington, DC 20010

Terms• Signing this agreement indicates

firm space commitment in accordance with the corresponding rate card. A signed copy of this agreement is binding.

• Advertising agency and/or client are liable should one or the other default. Cancellations are nonrefundable.

• All rates are net. Payment is due at space deadline. No agency or cash discounts are permitted. A minimum $500 late fee will be charged for materials received after the materials deadline.

• Advertiser agrees that the publisher’s liability (if any), due to omissions or errors in such advertising, shall in no event exceed the amount of charges for the listing or advertising which was omitted or in which the error occurred; liability shall be discharged by abatement of the charges or an advertising allowance commensurate with the error for the particular listing or advertising in which the omission or error occurred. No adjustments will be made to any free listing or advertisement.

Sign and return insertion orders to:Attn: Debbie Schapiro

MedStar Washington Hospital Center110 Irving Street, NWSuite 6B-4 Washington, DC 20010

t: 202.877.7998

e: [email protected]

Newspapers ad sizes and dimensionsPublication size: 9-1/2” x 13-1/4” (finished size)All dimensions are width x height.

Bleed 9-3/4" x 13-1/2" Trim 9-1/2" x 13-1/4" Live 9" x 12-3/4"

Back Coverand Full Page

Junior Page6" X 8-1/2"

Page 1 BannerBleed9-3/4" X 1-1/4"Trim9-3/4" x 1-1/4"Live9" x 1-1/4"

1/2 Page8-1/2" X 6”

1/4 Page4" X 6"

Bleed 19-1/4" x 13-1/2" Trim 19" x 13-1/4" Live 9" x 12-3/4"

Center Spread

Materials required for print products• PDF/X-1a files are

required for all ads. View specifications at www. swop.org or http://www.adobe.com/content/dam/Adobe/en/accessibility/products/acrobat/pdfs/acrobat-x-pdf-accessibility-best-practices.pdf.

• Fonts must be outlined or embedded.

• All colors should be converted to CMYK (except black text).

• Crop marks and color bars should be outside printable area (12-point offset).

• Only one ad per PDF document. (Submit full-page spreads as a single page.)

• URL for linking online version of display ad.

Document setup• Use Adobe InDesign for ad

layouts. For information on creating a PDF/X-1a, visit www.adobe.com.

• Photoshop: 300 dpi CMYK or grayscale, 600 dpi minimum bitmap, flattened layers, TIF or EPS format, binary encoding (no JPG and no extra channels).

• Illustrator: Outline all fonts, flatten transparencies, embed all elements (no links).

• All fonts should be Type 1 or OpenType (Multiple Master Fonts are strongly discouraged).

• All colors must be CMYK (except black text); no PMS/Pantone colors.

• Ink density is not to exceed 300%.

• Black text 12 points or smaller should be black only. (C=0%, M=0%, Y=0%, K=100%).

• Reversed text must be a minimum of 10 points.

Unacceptable file typesMicrosoft Word, Excel, PowerPoint, Publisher, Adobe Pagemaker, or Freehand files will not be accepted.

ProofsContract proofs are recommended for all ads. A contract proof printed at 100% with registration marks and color bars can be used for color accuracy, if SWOP-approved. View specifications online at www.swop.org. Without an accurate SWOP-provided proof, Ascend Integrated Media cannot be held responsible for the outcome of color on press.

Mail proofs to:Attn: Debbie SchapiroMedStar Washington Hospital Center110 Irving Street, NWSuite 6B-4 Washington, DC 20010

Please send final ads to:[email protected] and cc [email protected]

CRT DAILY PRINT SPECIFICATIONS

advertising opportunities - crt meeting...devoted to cardiogenic shock • updates on drug-coated...

Documents